ZYME
Price:
$26.52
Market Cap:
$1.99B
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers S...[Read more]
Industry
Biotechnology
IPO Date
2017-04-28
Stock Exchange
NASDAQ
Ticker
ZYME
According to Zymeworks Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -43935349065.00. This represents a change of 319.73% compared to the average of -10467408710.89 of the last 4 quarters.
The mean historical Enterprise Value of Zymeworks Inc. over the last ten years is 722.40M. The current -43935349065.00 Enterprise Value has changed -608284.21% with respect to the historical average. Over the past ten years (40 quarters), ZYME's Enterprise Value was at its highest in in the December 2020 quarter at 2.18B. The Enterprise Value was at its lowest in in the September 2025 quarter at -44635882560.00.
Average
722.40M
Median
484.21M
Minimum
125.46M
Maximum
2.15B
Discovering the peaks and valleys of Zymeworks Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 318.71%
Maximum Annual Enterprise Value = 2.15B
Minimum Annual Increase = -79.61%
Minimum Annual Enterprise Value = 125.46M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 1.06B | 81.78% |
| 2023 | 584.65M | 318.71% |
| 2022 | 139.63M | -79.61% |
| 2021 | 684.90M | -68.11% |
| 2020 | 2.15B | 33.83% |
| 2019 | 1.60B | 318.16% |
| 2018 | 383.76M | 205.87% |
| 2017 | 125.46M | -48.59% |
| 2016 | 244.04M | -0.94% |
| 2015 | 246.35M | 16.74% |
The current Enterprise Value of Zymeworks Inc. (ZYME) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
595.69M
5-year avg
923.93M
10-year avg
722.40M
Zymeworks Inc.’s Enterprise Value is less than Maze Therapeutics, Inc. (1.76B), less than Ardelyx, Inc. (1.58B), less than Spyre Therapeutics, Inc. (1.96B), less than Pharvaris N.V. (1.34B), less than Intellia Therapeutics, Inc. (925.20M), less than BioCryst Pharmaceuticals, Inc. (2.30B), less than Immunome, Inc. (1.70B), less than Trevi Therapeutics, Inc. (1.67B), less than Wave Life Sciences Ltd. (1.07B), less than Upstream Bio, Inc. (1.46B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.76B | $2.05B | |
| 1.58B | $1.42B | |
| 1.96B | $2.02B | |
| 1.34B | $1.80B | |
| 925.20M | $1.02B | |
| 2.30B | $1.65B | |
| 1.70B | $1.84B | |
| 1.67B | $1.73B | |
| 1.07B | $1.25B | |
| 1.46B | $1.50B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zymeworks Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zymeworks Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Zymeworks Inc.'s Enterprise Value?
What is the highest Enterprise Value for Zymeworks Inc. (ZYME)?
What is the 3-year average Enterprise Value for Zymeworks Inc. (ZYME)?
What is the 5-year average Enterprise Value for Zymeworks Inc. (ZYME)?
How does the current Enterprise Value for Zymeworks Inc. (ZYME) compare to its historical average?